Osteopore (ASX:OSX) has been green lit by Hong Kong’s Medical Device Control System (MDACS), offering the bone healing specialist the perfect staging ground into Greater China. — Read more

Osteopore shares digitalisation initiatives to increase efficiency. — Read more

In a major new development, bone healing company Osteopore (ASX:OSX) has been granted a patent in China for its ‘smart’ 3D biometric scaffolds. — Read more

Medical technology company Singular Health has partnered with innovative Australian scientific research agency CSIRO, on a project that is looking to develop an artificial intelligence-based tool to automatically design replacement “cranial implants” for 3D printing. The company has also entered into a collaboration with ASX-listed Osteopore to validate results of the project. — Read more

Regenerative implant innovators Osteopore and plastic and reconstructive surgeon Dr Michael Wagels have teamed up to conduct two ground-breaking human clinical trials. — Read more

After revolutionising reconstructive surgeries with regenerative implants that promote natural bone healing and tissue repair, Osteopore International is globalising its devices for broader use in dental, orthopaedic and spinal surgeries. — Read more

Medical technology company Osteopore (ASX: OSX) says the “robust capital position” it ended the June quarter in will enable it to take advantage of an expected increase in elective surgeries. — Read more

A recent article published in the Advance Science magazine discussed research by Monash University that uncovered a new technique to alter the shape of individual stem cells, which could potentially speed up recovery times for bone replacements. — Read more

Medtech company Osteopore (ASX: OSX) will soon have it’s 3D-printed bone regeneration products in the view of major international medical markets through a new collaboration with one of the world’s largest medical companies. — Read more